UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48

Circulation (New York, N.Y.), 2019-02, Vol.139 (6), p.760-771

2019

Volltextzugriff (PDF)

Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation

European journal of heart failure, 2023-06, Vol.25 (6), p.832-841

2023

Volltextzugriff (PDF)

Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

European heart journal, 2021-05, Vol.42 (17), p.1698-1706

2021

Volltextzugriff (PDF)

Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2019-11, Vol.140 (22), p.1792-1801

2019

Volltextzugriff (PDF)

Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial

Hypertension (Dallas, Tex. 1979), 2019-09, Vol.74 (3), p.597-605

2019

Volltextzugriff (PDF)

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

Circulation (New York, N.Y.), 2021-02, Vol.143 (7), p.673-684

2021

Volltextzugriff (PDF)

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial

Europace (London, England), 2021-01, Vol.23 (1), p.65-72

2021

Volltextzugriff (PDF)

First Experience with Edoxaban and Atrial Fibrillation Ablation – Insights from the ENGAGE AF-TIMI 48 Trial

International journal of cardiology, 2017-10, Vol.244, p.192-195

2017

Volltextzugriff (PDF)

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48)

Circulation. Arrhythmia and electrophysiology, 2017-01, Vol.10 (1), p.e004267-e004267

2017

Volltextzugriff (PDF)

A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study

The American heart journal, 2015-05, Vol.169 (5), p.597-604.e5

2015

Volltextzugriff (PDF)

EDOXABAN VERSUS WARFARIN IN ATRIAL FIBRILLATION ABLATION: FIRST EXPERIENCE FROM THE ENGAGE AF TIMI 48 TRIAL

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.366-366

2017

Volltextzugriff (PDF)

SUDDEN CARDIAC DEATH IN 21,105 PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE ENGAGE AF- TIMI 48 TRIAL

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.789-789

2016

Volltextzugriff (PDF)

The complete genome sequence of Thermoproteus tenax: a physiologically versatile member of the Crenarchaeota

PloS one, 2011-10, Vol.6 (10), p.e24222-e24222

2011

Volltextzugriff (PDF)

Transcriptomic complexity in young maize primary roots in response to low water potentials

BMC genomics, 2014-08, Vol.15 (1), p.741-741, Article 741

2014

Volltextzugriff (PDF)

Comparison of morphometric analysis based on T1- and T2-weighted MRI data for visualization of focal cortical dysplasia

Epilepsy research, 2013-10, Vol.106 (3), p.403-409

2013

Volltextzugriff (PDF)

Morphometric MRI analysis enhances visualization of cortical tubers in tuberous sclerosis

Epilepsy research, 2015-11, Vol.117, p.29-34

2015

Volltextzugriff (PDF)

Acute Effects of Intravenous Heroin on the Hypothalamic-Pituitary-Adrenal Axis Response: A Controlled Trial

Journal of clinical psychopharmacology, 2013-04, Vol.33 (2), p.193-198

2013

Volltextzugriff (PDF)

Congenital Diarrhea and Cholestatic Liver Disease: Phenotypic Spectrum Associated with MYO5B Mutations

Journal of clinical medicine, 2021-01, Vol.10 (3), p.481

2021

Volltextzugriff (PDF)

Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological results

Oncology reports, 1998-05, Vol.5 (3), p.549

1998

Volltextzugriff (PDF)

Assessment of motor blockade during epidural anesthesia

Anesthesia and analgesia, 1983-10, Vol.62 (10), p.889-893

1983

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(12)
Cardiovascular System & Cardiology
(10)
Atrial Fibrillation
(9)
Cardiac & Cardiovascular Systems
(9)
Female
(9)
Male
(9)
Middle Aged
(8)
Adult
(6)
Aged
(5)
Atrial Fibrillation - Drug Therapy
(5)
Factor Xa Inhibitors - Therapeutic Use
(5)
Pyridines - Therapeutic Use
(5)
Stroke
(5)
Thiazoles - Therapeutic Use
(5)
Anticoagulants
(4)
Anticoagulants - Therapeutic Use
(4)
Biological And Medical Sciences
(4)
Cardiovascular
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48

Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation

Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial

Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial

First Experience with Edoxaban and Atrial Fibrillation Ablation – Insights from the ENGAGE AF-TIMI 48 Trial

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48)

A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study

EDOXABAN VERSUS WARFARIN IN ATRIAL FIBRILLATION ABLATION: FIRST EXPERIENCE FROM THE ENGAGE AF TIMI 48 TRIAL

SUDDEN CARDIAC DEATH IN 21,105 PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE ENGAGE AF- TIMI 48 TRIAL

The complete genome sequence of Thermoproteus tenax: a physiologically versatile member of the Crenarchaeota

Transcriptomic complexity in young maize primary roots in response to low water potentials

Comparison of morphometric analysis based on T1- and T2-weighted MRI data for visualization of focal cortical dysplasia

Morphometric MRI analysis enhances visualization of cortical tubers in tuberous sclerosis

Acute Effects of Intravenous Heroin on the Hypothalamic-Pituitary-Adrenal Axis Response: A Controlled Trial

Congenital Diarrhea and Cholestatic Liver Disease: Phenotypic Spectrum Associated with MYO5B Mutations

Adjuvant therapy for gastric adenocarcinoma with the apoptosis-inducing human monoclonal antibody SC-1: first clinical and histopathological results

Assessment of motor blockade during epidural anesthesia

Aktive Filter

Suchergebnisse filtern